Role of community-level factors across the treatment cascade: A critical review

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue SUPPL.3, 2014, Pages

  Underwood, Carol ^a   Hendrickson, Zoé ^a   Van Lith, Lynn M ^a   Lengwe Kunda, John Eudes ^b   Mallalieu, Elizabeth C ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

community level factors; HIV AIDS; treatment cascade

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMMUNITY; COMMUNITY LEVEL FACTOR; COUNSELING; CULTURAL FACTOR; FOLLOW UP; GENDER; HEALTH CARE SYSTEM; HEALTH SERVICE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; NEIGHBORHOOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESOURCE ALLOCATION; SOCIAL NETWORK; SOCIAL SUPPORT; STIGMA; TREATMENT PLANNING;

HIV INFECTIONS; HUMANS; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT;

EID: 84904094143     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000234     Document Type: Article

References (111)

1. Mugglin C, Estill J, Wandeler G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: Systematic review and meta-analysis. Trop Med Int Health. 2012;17: 1509-1520.
2. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: A systematic review. PLoS Med. 2011;8: E1001056.
3. Kranzer K, Govindasamy D, Ford N, et al. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: A systematic review. J Int AIDS Soc. 2012;15(2): 17383.
4. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resourcelimited settings: Systematic review and meta-analysis. PLoS One. 2009;4:e5790.
5. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14:S11-S21.
6. Auerbach J. Transforming social structures and environments to help in HIV prevention. Health Aff (Millwood). 2009;28:1655-1665.
7. Gupta GR, Parkhurst JO, Ogden JA, et al. Structural approaches to HIV prevention. Lancet. 2008;372:764-775.
8. Underwood C, Skinner J, Osman N, et al. Structural determinants of adolescent girls' vulnerability to HIV: Views from community members in Botswana, Malawi, and Mozambique. Soc Sci Med. 2011;73: 343-350.
9. Kippax S, Stephenson N, Parker RG, et al. Between individual agency and structure in HIV prevention: Understanding the middle ground of social practice. Am J Public Health. 2013;103:1367-1375.
10. UNAIDS (Joint United National Programme on HIV/AIDS). Together we will end AIDS. Geneva: UNAIDS; 2012.
11. UNAIDS (Joint United National Programme on HIV/AIDS). Global report: UNAIDS report on the global AIDS epidemic. Geneva: UNAIDS; 2013.
12. Coates TJ. An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2013;63:S179-S182.
13. Macintyre S, Ellaway A, Cummins S. Place effects on health: How can we conceptualise, operationalise and measure them? Soc Sci Med. 2002; 55:125-139.
14. Song Y, Li X, Zhang L, et al. HIV-testing behavior among young migrant men who have sex with men (MSM) in Beijing, China. AIDS Care. 2011;23:179-186.
15. Beattie TSH, Parinita B, Suresh M, et al. Personal, interpersonal and structural challenges to accessing HIV testing, treatment and care services among female sex workers, men who have sex with men and transgenders in Karnataka state, south India. (special issue: Assessing the role of community mobilisation in a scaled HIV prevention programme among marginalized populations in India-findings from avahan). J Epidemiol Community Health. 2012;66(suppl 2):ii42-ii8.
16. Musheke M, Ntalasha H, Gari S, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13:220.
17. Lazarus L, Reza-Paul S, Pasha A, et al. Exploring the role of community-based peer support in improving access to care and antiretroviral treatment for sex workers in Mysore, India. J HIV AIDS Soc Serv. 2012;11:152-168.
18. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS. 2009;23:867-875.
19. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: A systematic review. AIDS. 2012;26:2059-2067.
20. Dam Anh T, Shakeshaft A, Anh Duc N, et al. Structural barriers to timely initiation of antiretroviral treatment in Vietnam: Findings from six outpatient clinics. PLoS One. 2012;7:e51289.
21. Kip E, Ehlers VJ, van der Wal DM. Patients' adherence to antiretroviral therapy in Botswana. J Nurs Scholarsh. 2009;41:149-157.
22. Kagee A, Remien RH, Berkman A, et al. Structural barriers to ART adherence in southern Africa: Challenges and potential ways forward. Glob Public Health. 2011;6:83-97.
23. Zhou YR. Help-seeking in a context of AIDS stigma: Understanding the healthcare needs of people with HIV/AIDS in China. Health Soc Care Community. 2009;17:202-208.
24. Xu J, Sullivan SG, Dou Z, et al. Economic stress and HIV-associated health care utilization in a rural region of China: A qualitative study. AIDS Patient Care & STDS. 2007;21:787-798.
25. Stephenson R, Miriam Elfstrom K, Winter A. Community influences on married men's uptake of HIV testing in eight African countries. AIDS Behav. 2013;17:2352-2366.
26. Kranzer K, McGrath N, Saul J, et al. Individual, household and community factors associated with HIV test refusal in rural Malawi. Trop Med Int Health. 2008;13:1341-1350.
27. Grant E, Logie D, Masura M, et al. Factors facilitating and challenging access and adherence to antiretroviral therapy in a township in the Zambian copperbelt: A qualitative study. AIDS Care. 2008;20:1155-1160.
28. Gari S, Malungo JRS, Martin-Hilber A, et al. HIV testing and tolerance to gender based violence: A cross-sectional study in Zambia. PLoS One. 2013;8(8):e71922.
29. Admassu M, Fitaw Y. Factors affecting acceptance of VCT among different professional and community groups in north and south Gondar administrative zones, north west Ethiopia. Ethiop J Health Dev. 2006; 20:24-31.
30. MacPhail CL, Pettifor A, Coates T, et al. "You must do the test to know your status": Attitudes to HIV voluntary counseling and testing for adolescents among South African youth and parents. Health Educ Behav. 2008;35:87-104.
31. Gregson S, Nyamukapa CA, Sherr L, et al. Grassroots community organizations' contribution to the scale-up of HIV testing and counselling services in Zimbabwe. AIDS. 2013;27:1657-1666.
32. Paz-Soldan VA, Bisika T, Graft-Johnson J, et al. Community, social group, and individual level correlates of rural Malawian men's and women's reproductive health intentions and practices. Afr J Reprod Health. 2012;16:57-67.
33. Underwood C, Boulay M, Snetro-Plewman G, et al. Community capacity as means to improved health practices and an end in itself: Evidence from a multi-stage study. Int Q Community Health Educ. 2012;33: 105-127.
34. Dageid W, Govender K, Gordon SF. Masculinity and HIV disclosure among heterosexual South African men: Implications for HIV/AIDS intervention. Cult Health Sex. 2012;14:925-940.
35. Mbonu NC, van den Borne B, De Vries NK. Stigma of people with HIV/AIDS in sub-Saharan Africa: A literature review. J Trop Med. 2009;2009:145891:1-14.
36. Babalola S. Readiness for HIV testing among young people in northern Nigeria: The roles of social norm and perceived stigma. AIDS Behav. 2007;11:759-769.
37. Abdool Karim Q, Meyer-Weitz A, Mboyi L, et al. The influence of AIDS stigma and discrimination and social cohesion on HIV testing and willingness to disclose HIV in rural KwaZulu-natal, South Africa. Glob Public Health. 2008;3:351-365.
38. Smolak A, El-Bassel N. Multilevel stigma as a barrier to HIV testing in central Asia: A context quantified. AIDS Behav. 2013;17:2742-2755.
39. Koku EF. Desire for, and uptake of HIV tests by Ghanaian women: The relevance of community level stigma. J Community Health. 2011;36: 289-299.
40. Tenkorang EY, Maticka-Tyndale E. Individual-and school-level correlates of HIV testing among secondary school students in Kenya. Stud Fam Plann. 2013;44:169-187.
41. Berendes S, Rimal RN. Addressing the slow uptake of HIV testing in Malawi: The role of stigma, self-efficacy, and knowledge in the Malawi BRIDGE project. J Assoc Nurses AIDS Care. 2011;22:215-228.
42. Bwambale FM, Ssali SN, Byaruhanga S, et al. Voluntary HIV counselling and testing among men in rural western Uganda: Implications for HIV prevention. BMC Public Health. 2008;8:263.
43. Day JH, Miyamura K, Grant AD, et al. Attitudes to HIV voluntary counselling and testing among mineworkers in South Africa: Will availability of antiretroviral therapy encourage testing? AIDS Care. 2003;15: 665-672.
44. Epule ET, Mirielle MW, Peng C, et al. Utilization rates and perceptions of (VCT) services in Kisii central district, Kenya. Glob J Health Sci. 2012;5:35-43.
45. Ford K, Wirawan DN, Sumantera GM, et al. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev. 2004;16:487-498.
46. Haraka F, Mohamed A, Kilonzo G, et al. Factors affecting HIV counselling and testing among adults in Muheza district, Tanzania. Tanzan J Health Res. 2012;14:1-5.
47. Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in cape town, South Africa. Sex Transm Infect. 2003;79:442-447.
48. Kitara DL, Aloyo J. HIV/AIDS stigmatization, the reason for poor access to HIV counseling and testing (HCT) among the youths in Gulu (Uganda). Afr J Infect Dis. 2012;6:12-20.
49. Koku EF. Stigma, sexual risk and desire for HIV tests in Ghana. Sex Health. 2011;8:110-119.
50. Leta TH, Syndoy IF, Fylkesnes K. Factors affecting voluntary HIV counselling and testing among men in Ethiopia: A cross-sectional survey. BMC Public Health. 2012;12:438.
51. Ma W, Detels R, Feng Y, et al. Acceptance of and barriers to voluntary HIV counselling and testing among adults in Guizhou province, China. (from science to policy: China's responses to HIV/AIDS). AIDS. 2007; 21(suppl 8):S129-S135.
52. Meiberg AE, Bos AER, Onya HE, et al. Fear of stigmatization as barrier to voluntary HIV counselling and testing in South Africa. East Afr J Public Health. 2008;5:49-54.
53. Mugo M, Kibachio C, Njuguna J. Utilization of voluntary counselling and testing services by women in a Kenyan village. J Rural Trop Public Health. 2010;9:36-39.
54. Wolfe WR, Weiser SD, Bangsberg DR, et al. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006;18:931-933.
55. Assefa Y, Van Damme W, Mariam DH, et al. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: Looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24:521-525.
56. MacPherson P, MacPherson EE, Mwale D, et al. Barriers and facilitators to linkage to ART in primary care: A qualitative study of patients and providers in Blantyre, Malawi. J Int AIDS Soc. 2012;15:18020.
57. Muhamadi L, Nsabagasani X, Tumwesigye MN, et al. Inadequate preantiretroviral care, stock-out of antiretroviral drugs and stigma: Policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD ,350 cells/micro L) in eastern Uganda. Health Policy. 2010;97:187-194.
58. Kakietek J, Geberselassie T, Manteuffel B, et al. It takes a village: Community-based organizations and the availability and utilization of HIV/AIDS-related services in Nigeria. AIDS Care. 2013;25(suppl 1): S78-S87.
59. Hodgson I, Nakiyemba A, Seeley J, et al. Only connect-the role of PLHIV group networks in increasing the effectiveness of Ugandan HIV services.. people living with HIV. AIDS Care. 2012;24:1368-1374.
60. Wouters E, Van Damme W, van Rensburg D, et al. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: A synthetic review. BMC Health Serv Res. 2012;12:194.
61. Chakrapani V, Newman PA, Murali S, et al. Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDS. 2009;23:973-980.
62. Chakrapani V, Newman PA, Murali S, et al. Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India. AIDS Care. 2011;23:1687-1694.
63. Saggurti N, Mishra RM, Proddutoor L, et al. Community collectivization and its association with consistent condom use and STI treatmentseeking behaviors among female sex workers and high-risk men who have sex with men/transgenders in Andhra Pradesh, India. AIDS Care. 2013;25(suppl 1):S55-S66.
64. Bila B, Egrot M. Gender asymmetry in healthcare-facility attendance of people living with HIV/AIDS in Burkina Faso. Soc Sci Med. 2009;69: 854-861.
65. Le Coeur S, Collins IJ, Pannetier J, et al. Gender and access to HIV testing and antiretroviral treatments in Thailand: Why do women have more and earlier access? Soc Sci Med. 2009;69:846-853.
66. Kunihira NR, Nuwaha F, Mayanja R, et al. Barriers to use of antiretroviral drugs in Rakai district of Uganda. Afr Health Sci. 2010;10: 120-129.
67. Mitchell SK, Kelly KJ, Potgieter FE, et al. Assessing social preparedness for antiretroviral therapy in a generalized AIDS epidemic: A diffusion of innovations approach. AIDS Behav. 2009;13:76-84.
68. Zamberia AM. HIV-related stigma and access to health care among people living with HIV in Swaziland. Dev South Afr. 2011;28:669-680.
69. Mill JE. Shrouded in secrecy: Breaking the news of HIV infection to Ghanaian women. J Transcult Nurs. 2003;14:6-16.
70. Adeeba K. Antiretroviral therapy in Malaysia: Identifying barriers to universal access. HIV Ther. 2009;3:573-582.
71. Kimani-Murage EW, Manderson L, Norris SA, et al. "It's my secret": Barriers to paediatric HIV treatment in a poor rural South African setting. AIDS Care. 2013;25:744-747.
72. Mtetwa S, Busza J, Chidiya S, et al. "You are wasting our drugs": Health service barriers to HIV treatment for sex workers in Zimbabwe. BMC Public Health. 2013;13:698.
73. Geiselhart K. Stigma and discrimination-an integrative perspective. Spatial disparities and their impact on the introduction of an antiretroviral therapy scheme for HIV and AIDS treatment in Botswana. Erdkunde. 2010;64:33-45.
74. Kruger A, Greeff M, Watson MJ, et al. Health care seeking behaviour of newly diagnosed HIV infected people from rural and urban communities in the North West province of South Africa. Afr J Nurs Midwifery. 2009;11:28-45.
75. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and metaanalysis. AIDS. 2009;23:1397-1404.
76. Campbell C, Skovdal M, Mupambireyi Z, et al. Building adherencecompetent communities: Factors promoting children's adherence to antiretroviral HIV/AIDS treatment in rural Zimbabwe. Health Place. 2012; 18:123-131.
77. Tomori C, Kennedy CE, Brahmbhatt H, et al. Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: The importance of socioeconomic and sociocultural factors. AIDS Care. 2014;26:907-913.
78. Jones DL, Zulu I, Vamos S, et al. Determinants of engagement in HIV treatment and care among Zambians new to antiretroviral therapy. J Assoc Nurses AIDS Care. 2013;24:e1-e12.
79. Skovdal M, Campbell C, Nhongo K, et al. Contextual and psychosocial influences on antiretroviral therapy adherence in rural Zimbabwe: Towards a systematic framework for programme planners. Int J Health Plann Manage. 2011;26:296-318.
80. Grimwood A, Fatti G, Mothibi E, et al. Community adherence support improves programme retention in children on antiretroviral treatment: A multicentre cohort study in South Africa. J Int AIDS Soc. 2012;15:17381.
81. Lyimo RA, Bruin MD, Boogaard JVD, et al. Determinants of antiretroviral therapy adherence in northern Tanzania: A comprehensive picture from the patient perspective. BMC Public Health. 2012;12:716.
82. Vreeman RC, Nyandiko WM, Ayaya SO, et al. Factors sustaining pediatric adherence to antiretroviral therapy in western Kenya. Qual Health Res. 2009;19:1716-1729.
83. Wouters E, Damme Wv, Loon Fv, et al. Public-sector ART in the free state province, South Africa: Community support as an important determinant of outcome. Social Sci Med. 2009;69:1177-1185.
84. Lifson AR, Demissie W, Tadesse A, et al. Barriers to retention in care as perceived by persons living with HIV in rural Ethiopia: Focus group results and recommended strategies. J Int Assoc Provid AIDS Care. 2013;12:32-38.
85. Merten S, Kenter E, McKenzie O, et al. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: A metaethnography. Trop Med Int Health. 2010;15(suppl 1):16-33.
86. Campbell C, Scott K, Nhamo M, et al. Social capital and HIV competent communities: The role of community groups in managing HIV/AIDS in rural Zimbabwe. AIDS Care. 2013;25(suppl 1):S114-S122.
87. Roura M, Busza J, Wringe A, et al. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: A follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009;23: 203-210.
88. Mimiaga MJ, Safren SA, Dvoryak S, et al. "We fear the police, and the police fear us": Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care. 2010;22:1305-1313.
89. Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: An ethnographic study. PLoS Med. 2009;6:e11.
90. Herrera C, Campero L, Caballero M, et al. Relationship between physicians and HIV patients: Influence on adherence and quality of life [in Spanish]. Rev Saude Publica. 2008;42:249-255.
91. Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 suppl l):S85-S93.
92. Braitstein P, Songok J, Vreeman RC, et al. "Wamepotea" (they have become lost): Outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr. 2011;57:e40-e46.
93. Van Dyk AC. Treatment adherence following national antiretroviral rollout in South Africa. Afr J AIDS Res. 2010;9:235-247.
94. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: A qualitative study. SAHARA J. 2008;5:136-143.
95. Jones D, Zulu I, Mumbi M, et al. Strategies for living with the challenges of HIV and antiretroviral use in Zambia. Int Electron J Health Educ. 2009;12:253-270.
96. Wasti SP, Simkhada P, Randall J, et al. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: A qualitative study. J Health Popul Nutr. 2012;30:410-419.
97. Musheke M, Bond V, Merten S. Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. J Int AIDS Soc. 2012;15(suppl 1):1-9.
98. Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, et al. Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: A qualitative study. PLoS One. 2013;8:e60073.
99. Van Tam V, Pharris A, Thorson A, et al. "It is not that I forget, it's just that I don't want other people to know": Barriers to and strategies for adherence to antiretroviral therapy among HIV patients in northern Vietnam. AIDS Care. 2011;23:139-145.
100. Okoror TA, Falade CO, Olorunlana A, et al. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria. AIDS Patient Care STDS. 2013;27:55-64.
101. Gilbert L, Walker L. "They (ARVs) are my life, without them I'm nothing"-experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place. 2009;15:1123-1129.
102. World Health Organization (WHO). Global update on HIV treatment 2013: Results, impact and opportunities. Geneva: World Health Organization; 2013.
103. Mburu G, Oxenham D, Hodgson I, et al. Community systems strengthening for HIV care: Experiences from Uganda. J Soc Work End Life Palliat Care. 2013;9:343-368.
104. Wube M, Horne CJ, Stuer F. Building a palliative care program in Ethiopia: The impact on HIV and AIDS patients and their families. J Pain Symptom Manage. 2010;40:6-8.
105. Zachariah R, Teck R, Buhendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007;101:79-84.
106. Bernays S, Rhodes T, Jankovic Terzic K. "You should be grateful to have medicines": Continued dependence, altering stigma and the HIV treatment experience in Serbia. AIDS Care. 2010;22:14-20.
107. Choi P, Kavasery R, Desai MM, et al. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010;21:416-423.
108. Rutledge SE, Abell N, Padmore J, et al. AIDS stigma in health services in the eastern Caribbean. Sociol Health Illn. 2009;31:17-34.
109. Ajayi B, Moses A, Gashau W, et al. Assessment of knowledge, perception and attitude of people living with HIV/AIDS toward HIV/AIDS in Maiduguri, northeast-Nigeria. Internet J Infect Dis. 2013;12:1.
110. Morrison SD, Banushi VH, Sarnquist C, et al. Barriers to care, and current medical and social needs of HIV-positive patients in Albania. Cent Eur J Public Health. 2011;19:91-97.
111. Busza JR. Promoting the positive: Responses to stigma and discrimination in southeast Asia. AIDS Care. 2001;13:441-456.